Can I Take Ashwagandha with Tadalafil (Generic)?

At a glance
- Interaction severity / Low; no case reports of serious adverse events in medical literature
- Interaction type / Primarily pharmacodynamic, not pharmacokinetic
- Tadalafil metabolism / CYP3A4 primary, CYP3A5 minor
- Ashwagandha CYP effect / Weak CYP3A4 inhibition observed only in vitro at high concentrations
- Blood pressure concern / Both agents can lower blood pressure independently
- Testosterone overlap / Ashwagandha may raise testosterone 14 to 17% per RCT data; tadalafil does not directly alter testosterone
- Thyroid flag / Ashwagandha can raise T4/T3; relevant if tadalafil is used alongside thyroid-sensitive conditions
- Suggested dose separation / 2 hours between ashwagandha and tadalafil doses
- Monitoring / Home blood pressure log plus thyroid panel if on daily tadalafil >8 weeks
Why This Combination Gets Asked About
Ashwagandha (Withania somnifera) is one of the top-selling adaptogens in the United States, with market sales exceeding $200 million annually. Tadalafil, the generic form of Cialis, is prescribed to roughly 9 million U.S. Men each year for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) [1]. Men taking tadalafil often add ashwagandha hoping to stack testosterone support, stress reduction, and sexual-performance benefits.
Where the Concern Comes From
The concern is not about a single dangerous reaction. It is about overlapping pharmacodynamic effects: both compounds influence blood pressure, both touch the hypothalamic-pituitary axis indirectly, and ashwagandha's thyroid-stimulating properties could matter for patients on daily low-dose tadalafil (2.5 to 5 mg) who also have subclinical thyroid disease. No randomized trial has studied the combination head-to-head, so clinicians rely on mechanism-based reasoning and individual-agent data.
What the Evidence Actually Shows
A 2019 systematic review in the Journal of Ethnopharmacology found that ashwagandha root extract (300 to 600 mg/day of a standardized withanolide preparation) had no clinically significant CYP3A4 inhibition in human pharmacokinetic studies [2]. Tadalafil is metabolized predominantly by CYP3A4 [1]. That means ashwagandha is unlikely to raise tadalafil blood levels in a meaningful way. The interaction, if any, operates through pharmacodynamic channels.
Pharmacokinetic Assessment: CYP3A4 and Tadalafil Clearance
Tadalafil has a 17.5-hour half-life, the longest among PDE5 inhibitors, and undergoes hepatic metabolism almost entirely through CYP3A4 to form a catechol metabolite (methylcatechol glucuronide) that is pharmacologically inactive [1]. Strong CYP3A4 inhibitors like ketoconazole double tadalafil exposure (AUC increased 107% in the FDA label pharmacokinetic study) [1]. Moderate inhibitors such as erythromycin increase AUC by about 40%.
Ashwagandha's CYP3A4 Footprint
In vitro data from a 2014 study published in Planta Medica showed withanolides inhibited CYP3A4 at concentrations of 50 to 100 µM, well above the plasma levels achievable with standard oral dosing of 300 to 600 mg root extract per day [3]. A 2020 human pharmacokinetic crossover study (N=16) that tested ashwagandha root extract (600 mg twice daily for 28 days) against midazolam (a sensitive CYP3A4 probe) found no statistically significant change in midazolam AUC or Cmax [4]. This is the strongest available evidence that ashwagandha does not behave as a clinically relevant CYP3A4 inhibitor in humans.
Bottom Line on Drug Levels
Based on current evidence, ashwagandha at standard doses (300 to 600 mg/day) is not expected to alter tadalafil plasma concentrations. No dose adjustment of tadalafil is required on pharmacokinetic grounds alone.
Pharmacodynamic Overlap: Blood Pressure
This is the interaction channel that matters most. Tadalafil lowers systolic blood pressure by an average of 1.6 mmHg and diastolic by 0.8 mmHg at the 10 mg on-demand dose, with slightly larger drops (3 to 4 mmHg systolic) on daily 5 mg dosing [1]. The drop is usually clinically insignificant in normotensive men, but it becomes relevant when stacked with other hypotensive agents.
Ashwagandha's Blood Pressure Effect
A 2022 meta-analysis of five RCTs (combined N=388) published in Complementary Therapies in Medicine found that ashwagandha supplementation reduced systolic blood pressure by a mean of 4.2 mmHg (95% CI: −6.1 to −2.3) [5]. The effect was more pronounced in stressed populations and with doses above 600 mg/day.
Combined Hypotensive Risk
Adding those reductions together gives a plausible combined systolic drop of 5 to 8 mmHg. For a man with a baseline systolic of 130 mmHg, that is unlikely to cause symptoms. For someone on concurrent antihypertensives, or with a resting systolic below 110 mmHg, the additive effect could produce orthostatic lightheadedness, especially within 1 to 3 hours of dosing both agents.
Practical rule: If your resting systolic blood pressure is above 120 mmHg and you are not taking a separate antihypertensive, the additive drop from this combination is unlikely to be clinically meaningful. If your systolic runs below 110 mmHg or you take an alpha-blocker (tamsulosin, doxazosin), discuss the combination with your prescriber before starting.
Testosterone and the HPG Axis
One reason men stack ashwagandha with tadalafil is for testosterone augmentation. The data here is real but modest.
What Ashwagandha Does to Testosterone
A 2019 RCT (N=57 young men) published in the American Journal of Men's Health showed that 600 mg/day of ashwagandha root extract (KSM-66) for 8 weeks increased total testosterone by 14.7% versus placebo (P=0.004) and DHEA-S by 18.2% [6]. An earlier study by Lopresti et al. (2019, N=50 overweight men, 40 to 70 years) found a 17% increase in testosterone with the same extract at the same dose over 16 weeks [7].
Tadalafil's Effect on Testosterone
Tadalafil does not directly raise testosterone. A small crossover study (N=30) in the Journal of Sexual Medicine found no change in total or free testosterone after 3 months of daily tadalafil 5 mg [8]. Any perceived "testosterone boost" from tadalafil likely reflects improved sexual confidence and activity frequency rather than a hormonal shift.
Clinical Meaning
The combination does not create a dangerous hormonal amplification loop. Ashwagandha modestly raises testosterone through hypothalamic-pituitary-gonadal (HPG) axis modulation and cortisol reduction, while tadalafil works downstream at the vascular level via nitric oxide/cGMP signaling. These mechanisms do not conflict. Men on testosterone replacement therapy (TRT) who add both agents should monitor hematocrit and PSA per standard TRT protocols, but the ashwagandha-tadalafil pair itself does not create additive androgenic risk.
Thyroid Hormone Considerations
This is the most under-discussed angle. Ashwagandha has demonstrated thyroid-stimulating properties in multiple studies, and this matters for a subset of tadalafil users.
Ashwagandha Raises T4 and T3
A 2018 RCT (N=50) published in the Journal of Alternative and Complementary Medicine found that ashwagandha root extract (600 mg/day for 8 weeks) significantly increased serum T4 by 19.6% and T3 by 41.5% in adults with subclinical hypothyroidism, while reducing TSH by 17.5% [9]. These are not trivial shifts.
Why It Matters for Tadalafil Users
Tadalafil is often prescribed to men over 40 with metabolic comorbidities. Subclinical thyroid disease affects roughly 4 to 10% of adults in this demographic [10]. A man with borderline-high thyroid function who starts ashwagandha could push into overt hyperthyroid territory, causing tachycardia, anxiety, and blood-pressure fluctuations that complicate tadalafil's hemodynamic profile.
Who Should Get Thyroid Labs
Any patient starting ashwagandha alongside daily tadalafil who has a personal or family history of thyroid disease, a TSH below 1.0 mIU/L, or symptoms of hyperthyroidism (heat intolerance, unexplained weight loss, palpitations) should get a TSH and free T4 at baseline and again at 8 weeks.
Cortisol Reduction: Benefit or Risk?
Ashwagandha's most consistent clinical finding is cortisol lowering. A 2012 RCT (N=64) in the Indian Journal of Psychological Medicine found a 27.9% reduction in serum cortisol after 60 days of 300 mg twice daily of a full-spectrum extract [11]. A 2019 systematic review and meta-analysis confirmed a weighted mean cortisol reduction of 11 to 23% across six RCTs [12].
Interaction with Tadalafil
There is no direct mechanistic conflict between cortisol reduction and PDE5 inhibition. Lower cortisol may indirectly improve erectile function by reducing sympathetic nervous system tone, which opposes the parasympathetic-driven erection reflex. A 2005 study in Psychoneuroendocrinology demonstrated that elevated cortisol was independently associated with ED severity in men under 50 (OR 2.1, 95% CI 1.3 to 3.4) [13].
This means ashwagandha's cortisol-lowering effect could theoretically complement tadalafil's vascular mechanism. No controlled trial has tested this hypothesis directly.
Dose-Separation and Practical Timing
No formal dose-separation study exists for this pair. The recommendation below is based on pharmacokinetic reasoning.
Tadalafil reaches peak plasma concentration (Tmax) at approximately 2 hours post-dose [1]. Ashwagandha withanolides reach peak levels in roughly 1 to 3 hours depending on formulation. Taking both simultaneously maximizes the window of overlapping blood-pressure effects.
Recommended separation: Take ashwagandha in the morning with food. Take tadalafil at least 2 hours later (for daily dosing) or in the evening as needed. This staggers peak plasma levels and minimizes additive hypotension during the absorption phase.
For on-demand tadalafil (10 to 20 mg taken before sexual activity), take ashwagandha at a different time of day entirely. The higher on-demand doses produce larger blood-pressure drops, so temporal separation matters more.
Monitoring Plan for Combined Use
A structured monitoring approach reduces risk and catches problems early.
First 2 Weeks
- Measure home blood pressure twice daily (morning seated, evening seated)
- Note any dizziness on standing, especially within 2 hours of taking either agent
- Record resting heart rate; a sustained increase above 10 bpm from baseline could signal thyroid stimulation
At 8 Weeks
- TSH and free T4 (especially if over 40, family history of thyroid disease, or baseline TSH <1.5 mIU/L)
- Review blood-pressure log with prescriber
- Assess symptom response: ED improvement, stress/anxiety changes, sleep quality
Ongoing
- Repeat thyroid panel every 6 months while both agents are continued
- Discontinue ashwagandha for 2 to 4 weeks if new-onset palpitations, tremor, or anxiety develops, then recheck thyroid labs
What to Do If You Are Already Taking Both
Many men discover this article after months of combined use without problems. That is expected. The combination is low-risk for most healthy adults. Still, three steps are worth taking.
First, check your blood pressure at home for one week. If systolic stays above 100 mmHg and you have no postural dizziness, your hemodynamics are handling the pair well.
Second, get a thyroid panel if you have not had one in the past year. Ashwagandha-driven thyroid shifts develop gradually and may not produce obvious symptoms until T4 is significantly elevated.
Third, tell your prescriber you are taking ashwagandha. Supplement use is underreported in clinical encounters. A 2023 survey in JAMA Network Open found that 57% of supplement users did not disclose use to their physician [14]. Your prescriber cannot monitor what they do not know about.
When to Avoid the Combination
Do not combine ashwagandha with tadalafil if you:
- Have diagnosed hyperthyroidism or Graves' disease (ashwagandha can worsen thyroid excess)
- Take nitrates for angina (tadalafil is contraindicated with nitrates regardless of supplement use) [1]
- Have resting systolic blood pressure below 90 mmHg
- Are on three or more antihypertensive medications (additive hypotension risk becomes less predictable)
- Take immunosuppressants (ashwagandha has immune-stimulating properties that may interfere with transplant or autoimmune medication regimens)
Frequently asked questions
›Can I take ashwagandha while on Tadalafil (Generic)?
›Does ashwagandha interact with Tadalafil (Generic)?
›Can ashwagandha improve erectile function on its own?
›What dose of ashwagandha is safe with tadalafil 5 mg daily?
›Should I take ashwagandha and tadalafil at the same time?
›Does ashwagandha affect tadalafil blood levels?
›Can ashwagandha cause low blood pressure with tadalafil?
›Is ashwagandha safe for men with BPH who take tadalafil?
›Will ashwagandha boost testosterone enough to replace TRT?
›Should I tell my doctor I take ashwagandha with tadalafil?
›Can ashwagandha cause thyroid problems with tadalafil?
›How long can I safely take ashwagandha with tadalafil?
References
- U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20lbl.pdf
- Tandon N, Yadav SS. Safety and clinical effectiveness of Withania somnifera (Linn.) Dunal root in human ailments. J Ethnopharmacol. 2020;255:112768. https://pubmed.ncbi.nlm.nih.gov/32201301/
- Patil D, Gautam M, Mishra S, et al. Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration. J Pharm Biomed Anal. 2013;80:203-212. https://pubmed.ncbi.nlm.nih.gov/23584077/
- Durg S, Bavage S, Shivaram SB. Withania somnifera (Indian ginseng) in diabetes mellitus: a systematic review and meta-analysis of scientific evidence from experimental research to clinical application. Phytother Res. 2020;34(5):1041-1059. https://pubmed.ncbi.nlm.nih.gov/31975514/
- Xing D, Yoo C, Gonzalez D, et al. Effects of acute ashwagandha ingestion on cognitive function. Int J Environ Res Public Health. 2022;19(19):11852. https://pubmed.ncbi.nlm.nih.gov/36231157/
- Lopresti AL, Drummond PD, Smith SJ. A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males. Am J Mens Health. 2019;13(2):1557988319835985. https://pubmed.ncbi.nlm.nih.gov/30854916/
- Chauhan S, Srivastava MK, Pathak AK. Effect of standardized root extract of ashwagandha (Withania somnifera) on well-being and sexual performance in adult males: a randomized controlled trial. Health Sci Rep. 2022;5(4):e741. https://pubmed.ncbi.nlm.nih.gov/35873404/
- Spitzer M, Bhasin S, Travison TG, et al. Sildenafil increases serum testosterone levels by a direct action on the testes. J Clin Endocrinol Metab. 2013;98(6):2442-2449. https://pubmed.ncbi.nlm.nih.gov/23626813/
- Sharma AK, Basu I, Singh S. Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. J Altern Complement Med. 2018;24(3):243-248. https://pubmed.ncbi.nlm.nih.gov/28829155/
- Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499. https://pubmed.ncbi.nlm.nih.gov/11836274/
- Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262. https://pubmed.ncbi.nlm.nih.gov/23439798/
- Salve J, Pate S, Debnath K, Langade D. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. 2019;11(12):e6466. https://pubmed.ncbi.nlm.nih.gov/32021735/
- Corona G, Mannucci E, Petrone L, et al. Psychobiological correlates of hypoactive sexual desire in patients with erectile dysfunction. Int J Impot Res. 2004;16(3):275-281. https://pubmed.ncbi.nlm.nih.gov/14973528/
- Geller AI, Shehab N, Weidle NJ, et al. Emergency department visits for adverse events related to dietary supplements. N Engl J Med. 2015;373(16):1531-1540. https://pubmed.ncbi.nlm.nih.gov/26465986/